![2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine structure](/static/products/844/844448-01-7.png)
2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
TL;DR: 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine (CAS 844448-01-7) is a chemical compound with molecular formula C22H26N2O3 and molecular weight 366.19 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine
Also Known As: 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine, 2-(3,4-dimethoxyphenyl)-5-isobutyl-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine, 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine
| Molecular Formula | C22H26N2O3 |
|---|---|
| Molecular Weight | 366.19 g/mol |
| LogP | 4.6195 |
| Topological Polar Surface Area | 43.29 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 366.19434 |
| Heavy Atoms | 27 |
| Complexity | 862.3864 |
Chemical Identifiers
| CAS Number | 844448-01-7 |
|---|---|
| SMILES | CC(C)CC1N2C(CC(=N2)C3=CC(=C(C=C3)OC)OC)C4=CC=CC=C4O1 |
Product Overview
2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine (CAS 844448-01-7), with molecular formula C22H26N2O3 and molecular weight 366.19 g/mol. IUPAC: 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine.
Chemical Property Profile of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
Property Insights of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
The XLogP value of 4.6195 indicates that 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 43.29 Ų, 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine has 0 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The CAS number of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is 844448-01-7.
What is the molecular formula of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The molecular formula of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is C22H26N2O3.
What is the molecular weight of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The molecular weight of 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is 366.19 g/mol.
Where can I buy 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
You can request a quote for 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
Yes, KEHONG BIO provides custom synthesis services for 2-(3,4-dimethoxyphenyl)-5-(2-methylpropyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.